KREITZER ANATOL (Chief Discovery Officer) sold 1.3% of their position (3.32K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $88.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/17/2026ACC: 0002021238-26-000006
Officer· Chief Discovery Officer
Since Feb 2026
-3.32K
Net shares
Net seller
$88.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.32K disposed
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
−3.32K
Price / share
$26.61
Trade value
$88.24K
% of position
1.3%
4/15/2026
259.93K→256.61K
Total
Net shares
−3.32K
Net value
-$88.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 4/15/2026 | S · Sale | −3.32K | $26.61 | $88.24K | 1.3% | 259.93K | 256.61K |
| Total | −3.32K | -$88.24K | ||||||
Derivative Transactions0
No derivative transactions reported